AB
TEVA icon

AT Bancorp’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

AT Bancorp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-18,727
Closed -$861K – 265
2016
Q3 		$861K Buy
+18,727
New +$977K 0.12% 164
2014
Q3 		– Sell
-32,884
Closed -$1.72M – 209
2014
Q2 		$1.72M Buy
+32,884
New +$1.68M 0.52% 71

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

AT Bancorp's TEVA Position: Q4 2016 in Review

AT Bancorp sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016, closing a stake of 18,727 shares — an estimated $861K sold.

AT Bancorp first reported a position in TEVA in Q2 2014 and held it in 2 quarters. The position peaked at $1.72M in Q2 2014. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • AT Bancorp reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2016 after selling out during the quarter.
  • AT Bancorp sold 18,727 Teva Pharmaceutical Industries Limited shares in Q4 2016, an estimated $861K.
  • AT Bancorp first reported a position in Teva Pharmaceutical Industries Limited in Q2 2014 and held it in 2 quarters.
  • AT Bancorp's Teva Pharmaceutical Industries Limited position peaked at $1.72M in Q2 2014.
  • 739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on AT Bancorp's 13F filing for Q4 2016, filed 8 Feb 2017.